Comparison of the life cycles of genetically distant species C and species D human adenoviruses Ad6 and Ad26 in human cells

Mallory A. Turner, Sumit Middha, Sean E. Hofherr, Michael A Barry

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Our understanding of adenovirus (Ad) biology is largely extrapolated from human species C Ad5. Most humans are immune to Ad5, so lower-seroprevalence viruses like human Ad6 and Ad26 are being tested as therapeutic vectors. Ad6 and Ad26 differ at the DNA level by 34%. To better understand how this might impact their biology, we examined the life cycle of the two viruses in human lung cells in vitro. Both viruses infected A549 cells with similar efficiencies, executed DNA replication with identical kinetics within 12 h, and began killing cells within 72 h. While Ad6-infected cells remained adherent until death, Ad26-infected cells detached within 12 h of infection but remained viable. Next-generation sequencing (NGS) of mRNA from infected cells demonstrated that viral transcripts constituted 1% of cellular mRNAs within 6 h and 8 to 16% within 12 h. Quantitative PCR and NGS revealed the activation of key early genes at 6 h and transition to late gene activation by 12 h by both viruses. There were marked differences in the balance of E1A and E1B activation by the two viruses and in the expression of E3 immune evasion mRNAs. Ad6 was markedly more effective at suppressing major histocompatibility complex class I (MHC I) display on the cell surface and in evading TRAIL-mediated apoptosis than was Ad26. These data demonstrate shared as well as divergent life cycles in these genetically distant human adenoviruses. An understanding of these differences expands the knowledge of alternative Ad species and may inform the selection of related Ads for therapeutic development.

Original languageEnglish (US)
Pages (from-to)12401-12417
Number of pages17
JournalJournal of Virology
Volume89
Issue number24
DOIs
StatePublished - 2015

Fingerprint

Human adenovirus D
Human Adenoviruses
Life Cycle Stages
life cycle (organisms)
Adenoviridae
Viruses
viruses
cells
Messenger RNA
Immune Evasion
Virus Activation
immune evasion
vertebrate viruses
Seroepidemiologic Studies
Biological Sciences
therapeutics
gene activation
Major Histocompatibility Complex
DNA Replication
major histocompatibility complex

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Comparison of the life cycles of genetically distant species C and species D human adenoviruses Ad6 and Ad26 in human cells. / Turner, Mallory A.; Middha, Sumit; Hofherr, Sean E.; Barry, Michael A.

In: Journal of Virology, Vol. 89, No. 24, 2015, p. 12401-12417.

Research output: Contribution to journalArticle

@article{f5c271f7541a4ea992bab49b85cd622e,
title = "Comparison of the life cycles of genetically distant species C and species D human adenoviruses Ad6 and Ad26 in human cells",
abstract = "Our understanding of adenovirus (Ad) biology is largely extrapolated from human species C Ad5. Most humans are immune to Ad5, so lower-seroprevalence viruses like human Ad6 and Ad26 are being tested as therapeutic vectors. Ad6 and Ad26 differ at the DNA level by 34{\%}. To better understand how this might impact their biology, we examined the life cycle of the two viruses in human lung cells in vitro. Both viruses infected A549 cells with similar efficiencies, executed DNA replication with identical kinetics within 12 h, and began killing cells within 72 h. While Ad6-infected cells remained adherent until death, Ad26-infected cells detached within 12 h of infection but remained viable. Next-generation sequencing (NGS) of mRNA from infected cells demonstrated that viral transcripts constituted 1{\%} of cellular mRNAs within 6 h and 8 to 16{\%} within 12 h. Quantitative PCR and NGS revealed the activation of key early genes at 6 h and transition to late gene activation by 12 h by both viruses. There were marked differences in the balance of E1A and E1B activation by the two viruses and in the expression of E3 immune evasion mRNAs. Ad6 was markedly more effective at suppressing major histocompatibility complex class I (MHC I) display on the cell surface and in evading TRAIL-mediated apoptosis than was Ad26. These data demonstrate shared as well as divergent life cycles in these genetically distant human adenoviruses. An understanding of these differences expands the knowledge of alternative Ad species and may inform the selection of related Ads for therapeutic development.",
author = "Turner, {Mallory A.} and Sumit Middha and Hofherr, {Sean E.} and Barry, {Michael A}",
year = "2015",
doi = "10.1128/JVI.01534-15",
language = "English (US)",
volume = "89",
pages = "12401--12417",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "24",

}

TY - JOUR

T1 - Comparison of the life cycles of genetically distant species C and species D human adenoviruses Ad6 and Ad26 in human cells

AU - Turner, Mallory A.

AU - Middha, Sumit

AU - Hofherr, Sean E.

AU - Barry, Michael A

PY - 2015

Y1 - 2015

N2 - Our understanding of adenovirus (Ad) biology is largely extrapolated from human species C Ad5. Most humans are immune to Ad5, so lower-seroprevalence viruses like human Ad6 and Ad26 are being tested as therapeutic vectors. Ad6 and Ad26 differ at the DNA level by 34%. To better understand how this might impact their biology, we examined the life cycle of the two viruses in human lung cells in vitro. Both viruses infected A549 cells with similar efficiencies, executed DNA replication with identical kinetics within 12 h, and began killing cells within 72 h. While Ad6-infected cells remained adherent until death, Ad26-infected cells detached within 12 h of infection but remained viable. Next-generation sequencing (NGS) of mRNA from infected cells demonstrated that viral transcripts constituted 1% of cellular mRNAs within 6 h and 8 to 16% within 12 h. Quantitative PCR and NGS revealed the activation of key early genes at 6 h and transition to late gene activation by 12 h by both viruses. There were marked differences in the balance of E1A and E1B activation by the two viruses and in the expression of E3 immune evasion mRNAs. Ad6 was markedly more effective at suppressing major histocompatibility complex class I (MHC I) display on the cell surface and in evading TRAIL-mediated apoptosis than was Ad26. These data demonstrate shared as well as divergent life cycles in these genetically distant human adenoviruses. An understanding of these differences expands the knowledge of alternative Ad species and may inform the selection of related Ads for therapeutic development.

AB - Our understanding of adenovirus (Ad) biology is largely extrapolated from human species C Ad5. Most humans are immune to Ad5, so lower-seroprevalence viruses like human Ad6 and Ad26 are being tested as therapeutic vectors. Ad6 and Ad26 differ at the DNA level by 34%. To better understand how this might impact their biology, we examined the life cycle of the two viruses in human lung cells in vitro. Both viruses infected A549 cells with similar efficiencies, executed DNA replication with identical kinetics within 12 h, and began killing cells within 72 h. While Ad6-infected cells remained adherent until death, Ad26-infected cells detached within 12 h of infection but remained viable. Next-generation sequencing (NGS) of mRNA from infected cells demonstrated that viral transcripts constituted 1% of cellular mRNAs within 6 h and 8 to 16% within 12 h. Quantitative PCR and NGS revealed the activation of key early genes at 6 h and transition to late gene activation by 12 h by both viruses. There were marked differences in the balance of E1A and E1B activation by the two viruses and in the expression of E3 immune evasion mRNAs. Ad6 was markedly more effective at suppressing major histocompatibility complex class I (MHC I) display on the cell surface and in evading TRAIL-mediated apoptosis than was Ad26. These data demonstrate shared as well as divergent life cycles in these genetically distant human adenoviruses. An understanding of these differences expands the knowledge of alternative Ad species and may inform the selection of related Ads for therapeutic development.

UR - http://www.scopus.com/inward/record.url?scp=84949845384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949845384&partnerID=8YFLogxK

U2 - 10.1128/JVI.01534-15

DO - 10.1128/JVI.01534-15

M3 - Article

C2 - 26423951

AN - SCOPUS:84949845384

VL - 89

SP - 12401

EP - 12417

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 24

ER -